TODD STRATEGY GROUP

Lobbying for MERCK & CO., INC. · Pharmaceutical Company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 20, 2026

Bills named in this filing 1

Lobbying activity 2

Health Issues

340B issues. Antimicrobial resistance. Supply Chain. Vaccine issues. Food and Drug Administration issues.

Medicare/Medicaid

Drug Pricing. S.864: HELP Copays Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.